Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Correction: The pleiotropic effects of TNFα in breast cancer subtypes is regulated by TNFAIP3/A20.

Lee E, Ouzounova M, Piranlioglu R, Ma MT, Guzel M, Marasco D, Chadli A, Gestwicki JE, Cowell JK, Wicha MS, Hassan KA, Korkaya H.

Oncogene. 2019 Jul;38(28):5749. doi: 10.1038/s41388-019-0838-y.

PMID:
31197211
2.

Plasticity and Potency of Mammary Stem Cell Subsets During Mammary Gland Development.

Lee E, Piranlioglu R, Wicha MS, Korkaya H.

Int J Mol Sci. 2019 May 13;20(9). pii: E2357. doi: 10.3390/ijms20092357. Review.

3.

Dietary myo-inositol chemoprevents lung carcinogenesis via boosting immune system in Kras mouse model.

Piranlioglu R, Korkaya H, Hassan KA.

J Thorac Dis. 2019 Mar;11(3):632-635. doi: 10.21037/jtd.2019.02.37. No abstract available.

4.

Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model.

Piranlioglu R, Lee E, Ouzounova M, Bollag RJ, Vinyard AH, Arbab AS, Marasco D, Guzel M, Cowell JK, Thangaraju M, Chadli A, Hassan KA, Wicha MS, Celis E, Korkaya H.

Nat Commun. 2019 Mar 29;10(1):1430. doi: 10.1038/s41467-019-09015-1.

5.

The co-chaperone UNC45A is essential for the expression of mitotic kinase NEK7 and tumorigenesis.

Eisa NH, Jilani Y, Kainth K, Redd P, Lu S, Bougrine O, Abdul Sater H, Patwardhan CA, Shull A, Shi H, Liu K, Elsherbiny NM, Eissa LA, El-Shishtawy MM, Horuzsko A, Bollag R, Maihle N, Roig J, Korkaya H, Cowell JK, Chadli A.

J Biol Chem. 2019 Apr 5;294(14):5246-5260. doi: 10.1074/jbc.RA118.006597. Epub 2019 Feb 8.

PMID:
30737284
6.

The EGFR T790M Mutation Is Acquired through AICDA-Mediated Deamination of 5-Methylcytosine following TKI Treatment in Lung Cancer.

El Kadi N, Wang L, Davis A, Korkaya H, Cooke A, Vadnala V, Brown NA, Betz BL, Cascalho M, Kalemkerian GP, Hassan KA.

Cancer Res. 2018 Dec 15;78(24):6728-6735. doi: 10.1158/0008-5472.CAN-17-3370. Epub 2018 Oct 17.

PMID:
30333118
7.

Thymoquinone prevents cisplatin neurotoxicity in primary DRG neurons.

Üstün R, Oğuz EK, Şeker A, Korkaya H.

Neurotoxicology. 2018 Dec;69:68-76. doi: 10.1016/j.neuro.2018.09.001. Epub 2018 Sep 15.

PMID:
30227172
8.

The pleiotropic effects of TNFα in breast cancer subtypes is regulated by TNFAIP3/A20.

Lee E, Ouzounova M, Piranlioglu R, Ma MT, Guzel M, Marasco D, Chadli A, Gestwicki JE, Cowell JK, Wicha MS, Hassan KA, Korkaya H.

Oncogene. 2019 Jan;38(4):469-482. doi: 10.1038/s41388-018-0472-0. Epub 2018 Aug 30. Erratum in: Oncogene. 2019 Jun 13;:.

9.

Thymoquinone protects DRG neurons from axotomy-induced cell death.

Üstün R, Oğuz EK, Şeker A, Korkaya H.

Neurol Res. 2018 Nov;40(11):930-937. doi: 10.1080/01616412.2018.1504157. Epub 2018 Aug 8.

PMID:
30088803
10.

Mimetics of suppressor of cytokine signaling 3: Novel potential therapeutics in triple breast cancer.

La Manna S, Lee E, Ouzounova M, Di Natale C, Novellino E, Merlino A, Korkaya H, Marasco D.

Int J Cancer. 2018 Nov 1;143(9):2177-2186. doi: 10.1002/ijc.31594. Epub 2018 Aug 11.

PMID:
29752723
11.

Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2+ Breast Cancer.

Yu X, Ghamande S, Liu H, Xue L, Zhao S, Tan W, Zhao L, Tang SC, Wu D, Korkaya H, Maihle NJ, Liu HY.

Mol Ther Nucleic Acids. 2018 Mar 2;10:317-330. doi: 10.1016/j.omtn.2017.12.015. Epub 2017 Dec 30.

12.

SALL1 expression in acute myeloid leukemia.

Salman H, Shuai X, Nguyen-Lefebvre AT, Giri B, Ren M, Rauchman M, Robbins L, Hou W, Korkaya H, Ma Y.

Oncotarget. 2017 Dec 15;9(7):7442-7452. doi: 10.18632/oncotarget.23448. eCollection 2018 Jan 26.

13.

SRC Increases MYC mRNA Expression in Estrogen Receptor-Positive Breast Cancer via mRNA Stabilization and Inhibition of p53 Function.

Abdullah C, Korkaya H, Iizuka S, Courtneidge SA.

Mol Cell Biol. 2018 Feb 27;38(6). pii: e00463-17. doi: 10.1128/MCB.00463-17. Print 2018 Mar 15.

14.

HET0016 decreases lung metastasis from breast cancer in immune-competent mouse model.

Borin TF, Shankar A, Angara K, Rashid MH, Jain M, Iskander A, Ara R, Lebedyeva I, Korkaya H, Achyut BR, Arbab AS.

PLoS One. 2017 Jun 13;12(6):e0178830. doi: 10.1371/journal.pone.0178830. eCollection 2017.

15.

Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade.

Ouzounova M, Lee E, Piranlioglu R, El Andaloussi A, Kolhe R, Demirci MF, Marasco D, Asm I, Chadli A, Hassan KA, Thangaraju M, Zhou G, Arbab AS, Cowell JK, Korkaya H.

Nat Commun. 2017 Apr 6;8:14979. doi: 10.1038/ncomms14979.

16.

Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast Cancers.

Noonepalle SK, Gu F, Lee EJ, Choi JH, Han Q, Kim J, Ouzounova M, Shull AY, Pei L, Hsu PY, Kolhe R, Shi F, Choi J, Chiou K, Huang TH, Korkaya H, Deng L, Xin HB, Huang S, Thangaraju M, Sreekumar A, Ambs S, Tang SC, Munn DH, Shi H.

Cancer Immunol Res. 2017 Apr;5(4):330-344. doi: 10.1158/2326-6066.CIR-16-0182. Epub 2017 Mar 6.

17.

Interplay between cell cycle and autophagy induced by boswellic acid analog.

Pathania AS, Guru SK, Kumar S, Kumar A, Ahmad M, Bhushan S, Sharma PR, Mahajan P, Shah BA, Sharma S, Nargotra A, Vishwakarma R, Korkaya H, Malik F.

Sci Rep. 2016 Sep 29;6:33146. doi: 10.1038/srep33146.

18.

Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers.

Linklater ES, Tovar EA, Essenburg CJ, Turner L, Madaj Z, Winn ME, Melnik MK, Korkaya H, Maroun CR, Christensen JG, Steensma MR, Boerner JL, Graveel CR.

Oncotarget. 2016 Oct 25;7(43):69903-69915. doi: 10.18632/oncotarget.12065.

19.

Elimination of epithelial-like and mesenchymal-like breast cancer stem cells to inhibit metastasis following nanoparticle-mediated photothermal therapy.

Paholak HJ, Stevers NO, Chen H, Burnett JP, He M, Korkaya H, McDermott SP, Deol Y, Clouthier SG, Luther T, Li Q, Wicha MS, Sun D.

Biomaterials. 2016 Oct;104:145-57. doi: 10.1016/j.biomaterials.2016.06.045. Epub 2016 Jun 23.

20.

Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancer.

Sun L, Burnett J, Gasparyan M, Xu F, Jiang H, Lin CC, Myers I, Korkaya H, Liu Y, Connarn J, He H, Zhang N, Wicha MS, Sun D.

Oncotarget. 2016 Aug 9;7(32):51408-51422. doi: 10.18632/oncotarget.9839.

21.

A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors.

Zhong H, Davis A, Ouzounova M, Carrasco RA, Chen C, Breen S, Chang YS, Huang J, Liu Z, Yao Y, Hurt E, Moisan J, Fung M, Tice DA, Clouthier SG, Xiao Z, Wicha MS, Korkaya H, Hollingsworth RE.

Cancer Res. 2016 Jan 15;76(2):480-90. doi: 10.1158/0008-5472.CAN-15-0883. Epub 2016 Jan 7.

22.

Trastuzumab resistance induces EMT to transform HER2(+) PTEN(-) to a triple negative breast cancer that requires unique treatment options.

Burnett JP, Korkaya H, Ouzounova MD, Jiang H, Conley SJ, Newman BW, Sun L, Connarn JN, Chen CS, Zhang N, Wicha MS, Sun D.

Sci Rep. 2015 Nov 2;5:15821. doi: 10.1038/srep15821.

23.

Notch reporter activity in breast cancer cell lines identifies a subset of cells with stem cell activity.

D'Angelo RC, Ouzounova M, Davis A, Choi D, Tchuenkam SM, Kim G, Luther T, Quraishi AA, Senbabaoglu Y, Conley SJ, Clouthier SG, Hassan KA, Wicha MS, Korkaya H.

Mol Cancer Ther. 2015 Mar;14(3):779-787. doi: 10.1158/1535-7163.MCT-14-0228. Epub 2015 Feb 11.

24.

The anti-angiogenic and cytotoxic effects of the boswellic acid analog BA145 are potentiated by autophagy inhibitors.

Pathania AS, Wani ZA, Guru SK, Kumar S, Bhushan S, Korkaya H, Seals DF, Kumar A, Mondhe DM, Ahmed Z, Chandan BK, Malik F.

Mol Cancer. 2015 Jan 21;14:6. doi: 10.1186/1476-4598-14-6.

25.

SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model.

Kim G, Ouzounova M, Quraishi AA, Davis A, Tawakkol N, Clouthier SG, Malik F, Paulson AK, D'Angelo RC, Korkaya S, Baker TL, Esen ES, Prat A, Liu S, Kleer CG, Thomas DG, Wicha MS, Korkaya H.

Oncogene. 2015 Feb 5;34(6):671-80. doi: 10.1038/onc.2014.4. Epub 2014 Feb 17.

26.

Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cells.

Lin L, Hutzen B, Lee HF, Peng Z, Wang W, Zhao C, Lin HJ, Sun D, Li PK, Li C, Korkaya H, Wicha MS, Lin J.

PLoS One. 2013 Dec 23;8(12):e82821. doi: 10.1371/journal.pone.0082821. eCollection 2013.

27.

HER2 and breast cancer stem cells: more than meets the eye.

Korkaya H, Wicha MS.

Cancer Res. 2013 Jun 15;73(12):3489-93. doi: 10.1158/0008-5472.CAN-13-0260. Epub 2013 Jun 5. Review.

28.

Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma.

Hassan KA, Wang L, Korkaya H, Chen G, Maillard I, Beer DG, Kalemkerian GP, Wicha MS.

Clin Cancer Res. 2013 Apr 15;19(8):1972-80. doi: 10.1158/1078-0432.CCR-12-0370. Epub 2013 Feb 26.

29.

HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab.

Ithimakin S, Day KC, Malik F, Zen Q, Dawsey SJ, Bersano-Begey TF, Quraishi AA, Ignatoski KW, Daignault S, Davis A, Hall CL, Palanisamy N, Heath AN, Tawakkol N, Luther TK, Clouthier SG, Chadwick WA, Day ML, Kleer CG, Thomas DG, Hayes DF, Korkaya H, Wicha MS.

Cancer Res. 2013 Mar 1;73(5):1635-46. doi: 10.1158/0008-5472.CAN-12-3349. Epub 2013 Feb 26.

30.

Breast cancer stem cells: we've got them surrounded.

Korkaya H, Wicha MS.

Clin Cancer Res. 2013 Feb 1;19(3):511-3. doi: 10.1158/1078-0432.CCR-12-3450. Epub 2012 Dec 18.

31.

Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors.

Petrillo LA, Wolf DM, Kapoun AM, Wang NJ, Barczak A, Xiao Y, Korkaya H, Baehner F, Lewicki J, Wicha M, Park JW, Spellman PT, Gray JW, Van't Veer L, Esserman LJ.

Breast Cancer Res Treat. 2012 Oct;135(3):913-22. doi: 10.1007/s10549-012-2226-y. Epub 2012 Sep 2.

32.

Lin28 and HER2: two stem cell regulators conspire to drive aggressive breast cancer.

Malik F, Korkaya H, Clouthier SG, Wicha MS.

Cell Cycle. 2012 Aug 1;11(15):2780-1. doi: 10.4161/cc.21395. Epub 2012 Aug 1. No abstract available.

33.

Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population.

Korkaya H, Kim GI, Davis A, Malik F, Henry NL, Ithimakin S, Quraishi AA, Tawakkol N, D'Angelo R, Paulson AK, Chung S, Luther T, Paholak HJ, Liu S, Hassan KA, Zen Q, Clouthier SG, Wicha MS.

Mol Cell. 2012 Aug 24;47(4):570-84. doi: 10.1016/j.molcel.2012.06.014. Epub 2012 Jul 19.

34.

MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells.

Liu S, Patel SH, Ginestier C, Ibarra I, Martin-Trevino R, Bai S, McDermott SP, Shang L, Ke J, Ou SJ, Heath A, Zhang KJ, Korkaya H, Clouthier SG, Charafe-Jauffret E, Birnbaum D, Hannon GJ, Wicha MS.

PLoS Genet. 2012;8(6):e1002751. doi: 10.1371/journal.pgen.1002751. Epub 2012 Jun 7.

35.

Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia.

Conley SJ, Gheordunescu E, Kakarala P, Newman B, Korkaya H, Heath AN, Clouthier SG, Wicha MS.

Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2784-9. doi: 10.1073/pnas.1018866109. Epub 2012 Jan 23.

36.

Breast cancer stem cells, cytokine networks, and the tumor microenvironment.

Korkaya H, Liu S, Wicha MS.

J Clin Invest. 2011 Oct;121(10):3804-9. doi: 10.1172/JCI57099. Epub 2011 Oct 3. Review.

37.

Inflammation and autophagy conspire to promote tumor growth.

Korkaya H, Wicha MS.

Cell Cycle. 2011 Aug 15;10(16):2623-4. Epub 2011 Aug 15. No abstract available.

PMID:
21829104
38.

Regulation of cancer stem cells by cytokine networks: attacking cancer's inflammatory roots.

Korkaya H, Liu S, Wicha MS.

Clin Cancer Res. 2011 Oct 1;17(19):6125-9. doi: 10.1158/1078-0432.CCR-10-2743. Epub 2011 Jun 17.

39.

Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks.

Liu S, Ginestier C, Ou SJ, Clouthier SG, Patel SH, Monville F, Korkaya H, Heath A, Dutcher J, Kleer CG, Jung Y, Dontu G, Taichman R, Wicha MS.

Cancer Res. 2011 Jan 15;71(2):614-24. doi: 10.1158/0008-5472.CAN-10-0538. Epub 2011 Jan 11. Erratum in: Cancer Res. 2011 Mar 15;71(6):2407.

40.

Cancer stem cells: nature versus nurture.

Korkaya H, Wicha MS.

Nat Cell Biol. 2010 May;12(5):419-21. doi: 10.1038/ncb0510-419. Epub 2010 Apr 25. No abstract available.

PMID:
20418873
41.

Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells.

Li Y, Zhang T, Korkaya H, Liu S, Lee HF, Newman B, Yu Y, Clouthier SG, Schwartz SJ, Wicha MS, Sun D.

Clin Cancer Res. 2010 May 1;16(9):2580-90. doi: 10.1158/1078-0432.CCR-09-2937. Epub 2010 Apr 13.

42.

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts.

Ginestier C, Liu S, Diebel ME, Korkaya H, Luo M, Brown M, Wicinski J, Cabaud O, Charafe-Jauffret E, Birnbaum D, Guan JL, Dontu G, Wicha MS.

J Clin Invest. 2010 Feb;120(2):485-97. doi: 10.1172/JCI39397. Epub 2010 Jan 4.

43.

Targeting breast stem cells with the cancer preventive compounds curcumin and piperine.

Kakarala M, Brenner DE, Korkaya H, Cheng C, Tazi K, Ginestier C, Liu S, Dontu G, Wicha MS.

Breast Cancer Res Treat. 2010 Aug;122(3):777-85. doi: 10.1007/s10549-009-0612-x. Epub 2009 Nov 7.

44.

Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling.

Korkaya H, Paulson A, Charafe-Jauffret E, Ginestier C, Brown M, Dutcher J, Clouthier SG, Wicha MS.

PLoS Biol. 2009 Jun 2;7(6):e1000121. doi: 10.1371/journal.pbio.1000121. Epub 2009 Jun 2.

45.

HER-2, notch, and breast cancer stem cells: targeting an axis of evil.

Korkaya H, Wicha MS.

Clin Cancer Res. 2009 Mar 15;15(6):1845-7. doi: 10.1158/1078-0432.CCR-08-3087. Epub 2009 Mar 10.

46.

HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.

Korkaya H, Paulson A, Iovino F, Wicha MS.

Oncogene. 2008 Oct 16;27(47):6120-30. doi: 10.1038/onc.2008.207. Epub 2008 Jun 30.

47.

[The cancer stem cell: the breast cancer driver].

Ginestier C, Korkaya H, Dontu G, Birnbaum D, Wicha MS, Charafe-Jauffret E.

Med Sci (Paris). 2007 Dec;23(12):1133-9. Review. French.

48.

Selective targeting of cancer stem cells: a new concept in cancer therapeutics.

Korkaya H, Wicha MS.

BioDrugs. 2007;21(5):299-310. Review.

PMID:
17896836
49.

Platelet-derived growth factor stimulates Src-dependent mRNA stabilization of specific early genes in fibroblasts.

Bromann PA, Korkaya H, Webb CP, Miller J, Calvin TL, Courtneidge SA.

J Biol Chem. 2005 Mar 18;280(11):10253-63. Epub 2005 Jan 5.

50.

The interplay between Src family kinases and receptor tyrosine kinases.

Bromann PA, Korkaya H, Courtneidge SA.

Oncogene. 2004 Oct 18;23(48):7957-68. Review.

PMID:
15489913

Supplemental Content

Loading ...
Support Center